Byetta Lawsuits Move Forward, With New Ruling Issued in Federal...

The Firm is evaluating Byetta lawsuits and other product liability claims that allege incretin mimetic diabetes drugs caused patients to develop pancreatic cancer, pancreatitis and thyroid cancer.(PRWeb September 24, 2014)Read the full story at http://www.prweb.com/releases/byetta-lawsuit/byetta-pancreatic-cancer/prweb12196939.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news